| haxxiy said: A number of states in Brazil didn't report yesterday, that's why the number was higher today.
I also discovered today the vaccines for SARS actually worked in animal tests back in the day where they were still being studied (albeit provoking some, erm, minor lung damage). I'm sure that knowledge is being useful in developing a vaccine nowadays.
I'm somewhat confident a moderately effective one will be available later this year. It will likely still cause you some bothersome side-effects after application and you might still develop a cold, but as long as hospitals aren't overcrowding, that's all good, right?
|
Ah, I wondered what the drop was in Brazil yesterday.
Looking at the 3 day average, the 'spike' today isn't even a spike, 112% week over week growth, actually less than 2 weeks ago (over 117%) but higher than last week (about 110%). The last time the world saw a bit of decline was May 14th, but only very slight (98% week over week change)
And yep, some of the vaccines in development are continuations from the work done on SARS vaccines. That stopped since an efficacy test wasn't possible anymore after the virus was stopped.
2 more added to phase 1 trials
https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
The one you're talking about is in there as well
PRECLINICAL 
After the SARS epidemic in 2002, Baylor College of Medicine researchers began developing a vaccine that could prevent a new outbreak. Despite promising early results, support for the research disappeared. Because the coronaviruses that cause SARS and Covid-19 are very similar, the researchers are reviving the project in partnership with the Texas Children’s Hospital.
Essay Pro